UNC Lineberger Comprehensive Cancer Center developed a pharmacist-led care model to make oncolytic virus treatments more efficient for patients and providers. By moving toxicity assessment, clinical review, and dose planning to pre-treatment telemedicine visits, the program reduced treatment time by more than 2 hours per session and helped decrease unnecessary clinic visits and drug waste.
2026 ACCC Innovator Award Winner UNC Lineberger Comprehensive Cancer Center noticed a common pain point among patients who received oncolytic virus treatment for advanced melanoma: time spent in appointments. To minimize the need for multiple lengthy appointments, the center developed a pharmacist-led strategy that utilized virtual visits and premixing doses prior to in-person visits.
In this episode, CANCER BUZZ speaks with 2026 ACCC Innovator Award winner Morgan Gwynn, PharmD, BCOP, CPP, an Oncology Clinical Pharmacist Practitioner at UNC Lineberger, about her program’s development of a pharmacist-led care model to make oncolytic virus treatments more efficient for patients and providers. By moving toxicity assessment, clinical review, and dose planning to pre-treatment telemedicine visits, the program reduced treatment time by more than 2 hours per session and helped decrease unnecessary clinic visits and drug waste.